CAVEOLAE, BULB-SHAPED INVAGINATIONS of the plasma membrane, are a characteristic feature of endothelial cells, smooth muscle cells, adipocytes, and fibroblasts (32) . Caveolae may be important for cellular functions such as signal transduction, transcytosis across endothelia, pinocytosis, and endocytosis (1, 25, 26) . Caveolin is a 21-to 24-kDa protein that is an important structural and regulatory component of caveolae membranes (24, 28) . Caveolin may modulate residential signaling molecules in caveolae. For example, in endothelial and cardiac myocyte cell lysates, endothelial nitric oxide (NO) synthase (eNOS) coimmunoprecipitates with caveolin-1 and caveolin-3, respectively (5, 7). Protein-protein interactions of eNOS with caveolins, are necessary for eNOS to be targeted to golgi membranes and plasmalemma caveolae for processes such as myristoylation, palmitoylation, and tyrosine phosphorylation of the enzyme (5, 9) . In in vitro experiments, over expression of eNOS and caveolin-1 in COS-7 cells revealed that both NH 2 -and COOH-terminal domains of caveolin interact directly with the eNOS oxygenase domain and inhibit eNOS catalytic activity (8, 15, 22, 23) .
17␤-Estradiol is a physiological regulator of eNOS and significantly enhances eNO production in animals and human through both genomic and nongenomic mechanisms (2-4, 12, 13, 16, 29, 30, 33) . However, there are no reports demonstrating temporal relationships among estrogen treatment, NO production, and caveolin expression in endothelial cells. Hence, the present study was designed to determine effects of 17␤-estradiol treatment on caveolin-1 expression and NOS by eNOS in cultured bovine aortic endothelial cells (BAECs).
MATERIALS AND METHODS
Chemicals. The 17␤-estradiol, 17␣-estradiol, Tris (hydroxymethyl)aminomethane, glycine, and sodium ortho-vanadate were purchased from Sigma (St. Louis, MO). ICI-182,780 was bought from Zeneca Pharmaceuticals. Monoclonal anti-eNOS-3 (N30020) antibody and anti-caveolin-1 (C13620) monoclonal antibody were purchased from Transduction Laboratories (Lexington, KY). All other reagents and solvents used in this study were of analytic/ reagents grade.
Cell culture. BAECs were isolated from fetal calves of either sex and cultured at 37°C in a humidified atmosphere of 95% O 2-5% CO2 using Dulbecco's modified Eagle's medium containing 10% (vol/vol) calf serum, penicillin (100 U/ml), streptomycin (100 g/ml), and L-glutamate (2 mM). Before experimentation, cells were passaged by trypsin-EDTA [0.05% and 0.02% (wt/vol), respectively], seeded onto 6-cm culture plates at a minimum of 1 ϫ 10 6 cells per plate, and allowed to 80-90% confluent. Cells of passages 4-8 were used in all experiments. Cells were cultured in medium supplemented 2% charcoal-stripped calf serum. After cells were confluenced, culture medium was replaced by fresh phenolred-free medium with and without 17␣-estradiol, 17␤-estradiol (10 Ϫ10 to 10 Ϫ8 M), ICI-182,780 (10 Ϫ6 M), or a combination of 17␤-estradiol and ICI-182,780. Experiments were terminated after 12, 24, and 48 h of test treatment.
Determination of caveolin-1 expression. Cultures of BAECs were washed in PBS and lysed with 0.5 ml of boiling lysis buffer (1% SDS, 1 mM sodium vanadate, and 10 mM Tris pH 7.4). The lysate was briefly sonicated or put by several passages through a 26-gauge needle and then centrifuged in 4°C at 10,000 rpm for 5 min to remove the insoluble material. The supernatant was separated and used for total protein determination by the method of Lowry et al. (18) . The remaining samples were mixed with equal volume of 2ϫ electrophoresis sample buffer (1ϫ ϭ 125 mM Tris ⅐ HCl, pH 6.8, 2% SDS, 5% glycerol, 0.003% bromophenol blue, and 1% ␤-mercaptoethanol) and heated at 95°C for 5 min. Equal amounts of heated samples (15 g) were loaded and separated on 12% SDSpolyacrylamide gel. After electrophoretic separation, proteins were transferred onto a polyvinylidene difluoride membrane (Japan Genetics, Tokyo, Japan). The membrane was blocked with 5% nonfat dry milk in transfer buffer (25 mM Tris, 190 mM glycine, and 20% methanol) for 1 h and then was incubated at 4°C with primary anti-caveolin-1 isotype mouse IgM (C13620; 1:500 dilution in transfer buffer) antibody overnight (7, 14) . Membranes were washed in transfer buffer three times at 5-min intervals, incubated with biotinylated secondary anti-mouse IgM antibody at a dilution of 50 l in 10 ml of transfer buffer for 45 min, and then washed three times in transfer buffer for 5 min each. The washed membrane was conjugated with avidin-biotin complex (ABC) reagent prepared 30 min before in the combination of reagent A (100 l) and reagent B (100 l) in 5 ml of transfer buffer (ABC Kit, Vector Laboratories, Vectastain, CA). The conjugated membrane was washed in transfer buffer three times and then treated with diaminobenzidine reagent prepared according to manufacturer instructions (4100, Vector Laboratories) for 3-4 min (14) . The caveolin-1 expression was visualized on the membrane.
Evaluation of eNOS protein expression. eNOS protein expression in BAECs was determined as described above for caveolin-1 determination except that the primary antibody was anti-eNOS monoclonal antibody isotype mouse IgG1 (N30020; 1:1,000 dilution in transfer buffer), and the secondary antibody was biotinylated anti-mouse IgG (50 l in 10 ml transfer buffer) in 7.5% SDS-polyacrylamide gel. Equal amounts of BAEC lysate (40 g of protein) were loaded to all lanes.
Determination of caveolin-1 mRNA expression. Total RNA was isolated from these BAEC cultures with 1-ml TRIzol reagent according to manufacturer protocol (GIBCO BRL, Life Technologies, Gaithersburg, MD). Total RNA of all samples was quantified by measuring the optical density at 260 nm. Ten micrograms of RNA samples (4 l) were mixed with freshly prepared sample buffer (16 l) [formamide (200 l), formaldehyde (70 l), 5ϫ dye (40 l), 10ϫ MOPS (40 l), and 10 mg/ml of ethidium bromide (3 l)]; heated at 65°C for 5 min; and then cooled in ice for 3 min. The cooled samples (10 g of RNA) were added to all lanes and electrophoresed on 1% agarose-formaldehyde denaturing gel using 1ϫ MOPS running buffer (10ϫ MOPS contains 0.4 M MOPS pH 7, 10 mM EDTA, and 0.1 M sodium acetate). After electrophoresis, RNA was transferred to a nylon membrane by capillary blotting. The RNA-transferred membrane was washed in 3ϫ SSC (0.9 M sodium chloride and 0.09 M sodium citrate) for 3 min with shaking and dried for 5 min at room temperature. The dried membrane was immobilized by ultraviolet autocross linking. The RNA-transferred membrane was prepared with prehybridization buffer (15560-014, GIBCO BRL) for 2-4 h and hybridized to full-length random-primed [␣-
32 P]dCTP-labeled caveolin-1 cDNA (GenBank Accession No. AA047106) probe (prepared by RPN1633, Rediprime II DNA labeling kit; Amersham Pharmacia Biotech) for overnight at 65°C using hybridization buffer (15565-013, GIBCO BRL). After overnight hybridization, the membrane was washed two times in 2ϫ SSC containing 0.1% SDS, and two additional washes were done in 1ϫ SSC containing 0.1% SDS and in 0.1ϫ SSC containing 0.1% SDS for 15 min in each wash at 65°C and dried. Autoradiograpy was carried out in the dried membrane by using an imaging plate overnight. The imaging plate was read in a computer using an imaging plate reader and scanned with computerized densitometer (BAStation, Fuji; Tokyo, Japan), under conditions where the 
signal was linear with the amount of sample applied. Band density was normalized to the intensity of ethidium bromidestained 28S ribosomal RNA (14) .
Nitrite/nitrate measurement. After 17␤-estradiol treatment, cell culture medium was collected from each plate at different time intervals (12, 24 , and 48 h) for the determination of nitrite (NO 2 Ϫ )/nitrate (NO 3 Ϫ ) level. The stable end products of NO 2 Ϫ /NO 3 Ϫ break down were measured using an automated high-performance liquid chromatography procedure (ENO10: Eicom, Kyoto, Japan) where nitrate is converted to nitrite in an in-line copper-coated cadmium column, and then nitrite is detected based on the Griess reaction (34) .
Statistical analysis. All Western and Northern blot experiments were carried out independently in samples prepared from a minimum of four separate cultures. Preliminary experiments were conducted to determine linearity for Western blot experiments. Results of nitrite/nitrate production (NO x) and densitometric analysis of Northern and Western blots are presented as means Ϯ SD. Statistical significance of results in the absence and presence of 17␤-estradiol over time was evaluated by analysis of variance. When a significant F value was found, means were compared by Bonferroni's multiple comparison test. Differences at P Ͻ 0.05 were considered significant. 
RESULTS
Under control conditions (absence of 17␤-estradiol), mRNA and caveolin-1 protein were detected ( Figs. 1 and 2) . Treatment of cells with 17␤-estradiol increased expression of caveolin-1 mRNA after 48 h of treatment (Fig. 1) . This increase in mRNA coincided with a statistically significant increase in protein expression (Fig. 2) . Increases in both caveolin-1 mRNA and protein were observed with the lowest dose of estrogen (10 Ϫ10 M) and did not increase further concentrations of estrogen (10 Ϫ8 M). The estrogen receptor antagonist ICI-182,180 (10 Ϫ6 M) inhibited up to 70-80% of the increase of caveolin-1 mRNA and protein expression in response to 17␤-estradiol treatment for 48 h (Figs. 3 and 4) . Treatment with 17␣-estradiol for either 12, 24, or 48 h did not significantly alter caveolin-1 mRNA or protein expression (data not shown).
eNOS protein was increased significantly after 24-and 48-h exposure of 17␤-estradiol (Fig. 5) . 17␤-estradiol-induced eNOS protein expression was also inhibited by estrogen receptor modulator ICI-182, 180 (data not shown). NO x production increased significantly only after 24 h of 17␤-estradiol treatment (Fig. 6A) . The E 2 -mediated increased NO x synthesis was inhibited up to 80% in 17␤-estradiol treated with estrogen receptor antagonist ICI-182,180 (10 Ϫ6 M) (Fig. 6B) .
DISCUSSION
Results of the present study demonstrate for the first time temporal relationships among 17␤-estradiol treatment and expression of NOS with caveolin-1 mRNA and protein in BAECs. Our finding that 17␣-estradiol did not increase either NOS or caveolin-1 supports the conclusion that effects were specific to 17␤-estradiol and not due to a generalized nonspecific effect of steroid hormones. The estrogen receptor antagonist ICI-182,780 inhibited caveolin-1 mRNA and protein expression in response to 17␤-estradiol treatment, which suggests that 17␤-estradiol stimulates caveolin-1 transcription and translation through estrogen receptor-mediated mechanisms. All gels were loaded with equal quantities of protein and mRNA, thus normalizing the evaluations to account for increases in other transcriptional and translational events influenced by estrogen treatment. The antibody for caveolin-1 used in these experiments does not differentiate between the ␣-or ␤-isoforms of caveolin-1. However, the observation of a single band on the Western blot corresponded to a band expressed using another monoclonal anti- caveolin-1 antibody (14) . The lack of a dose-response effect of estrogen treatment on caveolin-1 expression may reflect saturation of the estrogen receptors with the lowest dose of estrogen. Caveolin-1 expression directly correlates with caveolae number (6, 11, 17) . Therefore, results suggest that estrogen may influence the number of caveolae present on a cell surface through regulation of caveolin-1.
Caveolin-1 itself may also affect genomic actions of estrogen. Coexpression of caveolin-1 and estrogen receptor-␣ (ER␣) resulted in independent translocation of ER␣ to the nucleus (31) . Caveolin-1 may act as a transcription factor for genes that contain estrogen response elements because caveolin-1 augmented both ligand-dependent and ligand-independent ER␣ signaling (31) . Therefore, increased expression of caveolin-1 in response to E 2 treatment in this study may also modulate ER␣ transport to the nucleus to modulate other genomic actions of estrogen. ER␣ is present in caveolae where rapid nongenomic actions such as regulation of eNOS may occur (21, 31) . Caveolin-1 expression in pial arteries from ovariectomized rats treated with estrogen for 2 wk decreased from that of pial arteries from untreated ovariectomized animals to a level of that of arteries from intact females (27) . These results support the fact that estrogen can regulate caveolin-1 expression in whole arteries as well as cultured endothelial cells. However, direct comparison between studies using intact animals and cells in cultures should be made with caution. For example, duration and dose of estrogen treatment was not the same in the two types of experiments. In addition, changes in protein expression in endothelial cells of arteries from whole animal experiments would represent combined effects of estrogen and cytokine interactions from other cell types, such as smooth muscle cells and blood elements, as well as changes in mechanical factors such as shear stress. Cells in culture, of course, are not influenced by these factors and may differentiate over time. However, only cells of passages 4-8, which are known to retain responsiveness to 17␤-estradiol, were used in these experiments (13) . Caveolin-1 is found in many cell types, including smooth muscle and fibroblasts (32) , and estrogen may regulate expression in these cells as well.
Results of the present study also confirm other observations that estrogen treatment increases eNOS protein expression (13) . Results of the present study extend these observations to show a timedependent change in NO x production such that NO x levels increased significantly with 24 h of treatment but decreased after 48 h even when protein remained elevated. Endothelial NOS activity is regulated by its subcellular localization, by phosphorylation, and through its interaction with different cellular proteins (5, 19) . The eNOS and caveolin-1 association in caveolae is believed to maintain eNOS in an inactive state (10) . The control of eNOS activity by caveolin is probably required to maintain a low basal production of NO and protect the cell from undesired, potentially cytotoxic, bursts of NO in response to subtle increases in intracellular calcium (20) . It is possible to speculate that decreased NO x with 48-h treatment of estrogen may reflect increased caveolin-eNOS interaction resulting from elevated production of caveolin-1. This speculation is consistent with a reciprocal relationship between caveolin-1 and eNOS expression in pial arteries from ovariectomized rats treated with estrogen (27) .
In summary, estrogen affects endothelial functions through several mechanisms. Results of the present study provide evidence that 17␤-estradiol increases gene transcription and translation of caveolin-1 in endothelial cells. Therefore, in addition to direct effects of estrogen on NO x production through genomic and nongenomic activation of eNOS, estrogen may also indirectly protect against overproduction of NO x through increases in production of caveolin-1.
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